Johnson & Johnson asked rival COVID-19 vaccine makers to probe clotting risks

Johnson & Johnson had reached out to rival COVID-19 vaccine makers to join in an effort to study the risks of blood clots, the Wall Street Journal reported on Friday, citing people familiar with the matter.